Literature DB >> 17389899

Is rs7566605, a SNP near INSIG2, associated with body mass in a randomized clinical trial of antipsychotics in schizophrenia?

T Skelly, A P Pinheiro, L A Lange, P F Sullivan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389899     DOI: 10.1038/sj.mp.4001956

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  5 in total

Review 1.  Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.

Authors:  Chao Luo; Junyan Liu; Xu Wang; Xiaoyuan Mao; Honghao Zhou; Zhaoqian Liu
Journal:  Neurosci Bull       Date:  2019-01-03       Impact factor: 5.203

2.  Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program.

Authors:  P W Franks; K A Jablonski; L M Delahanty; J B McAteer; S E Kahn; W C Knowler; J C Florez
Journal:  Diabetologia       Date:  2008-10-07       Impact factor: 10.122

3.  INSIG2 SNPs associated with obesity and glucose homeostasis traits in Hispanics: the IRAS Family Study.

Authors:  Matthew E Talbert; Carl D Langefeld; Julie T Ziegler; Steven M Haffner; Jill M Norris; Donald W Bowden
Journal:  Obesity (Silver Spring)       Date:  2009-04-09       Impact factor: 5.002

4.  Association of INSIG2 polymorphism with overweight and LDL in children.

Authors:  Anne-Marie Kaulfers; Ranjan Deka; Lawrence Dolan; Lisa J Martin
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

5.  Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case-control study.

Authors:  Natalia Jimeno; Veronica Velasco-Gonzalez; Inmaculada Fierro; Mercedes Duran; Alfonso Carvajal
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.